METHOD FOR GENERATION AND REGULATION OF IPS CELLS AND COMPOSITIONS THEREOF

• US 20110189137A1
• Filed: 11/10/2010
• Published: 08/04/2011
• Est. Priority Date: 11/11/2009
• Status: Abandoned Application

• Current Assignee: Sanford-Burnham Medical Research Institute (Sanford Burnham Prebys Medical Discovery Institute)
• Original Assignee: Sanford-Burnham Medical Research Institute (Sanford Burnham Prebys Medical Discovery Institute)
• Inventors: Rana, Tariq M.
• Application Number:
  US12/943,833
• Publication Number:
  US 20110189137A1
• Time in Patent Office: Days
• US Class Current: 424/93.7
• CPC Class Codes: A61P 43/00 Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
• CPC Class Codes: C12N 15/113 Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing when used in plants C12N15/8218
• CPC Class Codes: C12N 2310/113 targeting other non-coding nucleic acids, e.g. antagomirs
• CPC Class Codes: C12N 2310/141 MicroRNAs, miRNAs
• CPC Class Codes: C12N 2501/602 Sox-2
• CPC Class Codes: C12N 2501/603 Oct-3/4
• CPC Class Codes: C12N 2501/604 Klf-4
• CPC Class Codes: C12N 2501/606 c-Myc
• CPC Class Codes: C12N 2501/65 MicroRNA
• CPC Class Codes: C12N 2501/998 Proteins not provided for elsewhere
• CPC Class Codes: C12N 2510/00 Genetically modified cells
• CPC Class Codes: C12N 5/0696 Artificially induced pluripotent stem cells, e.g. iPS

Abstract

The present invention provides methods for generating induced pluripotent stem (iPS) cells having an increased efficiency of induction as compared with conventional methods. The method includes treating a somatic cell with a nuclear reprogramming factor in combination with an agent that alters microRNA levels or activity in the cell and/or a p21 inhibitor. The invention further provides iPS cells generated by such methods, as well as clinical and research uses for such iPS cells.

Claims

1. A method of generating an induced pluripotent stem (iPS) cell comprising:

a) contacting a somatic cell with a nuclear reprogramming factor; and

b) contacting the cell of (a) with a microRNA that alters RNA levels or activity within the cell, thereby generating an iPS cell.

2. The method of claim 1, wherein the microRNA or RNA is modified.

3. The method of claim 1, wherein the microRNA is in a vector.

4. The method of claim 1, wherein the microRNA is in the miR-17, miR-25, miR-106a, miR let-7 family member or miR-302b cluster.

5. The method of claim 1, wherein the microRNA is miR-93, miR-106b, miR-21, miR-29a, or a combination thereof.

6. The method of claim 1, wherein the microRNA has a polynucleotide sequence comprising SEQ ID NO:

1.

7. The method of claim 1, wherein the microRNA has a polynucleotide sequence selected from the group consisting of SEQ ID NOs:

2-11.

8. The method of claim 1, wherein the microRNA regulates expression or activity of p21, Tgfbr2, p53, Ago2, or a combination thereof.

9. The method of claim 1, wherein the microRNA regulates Spry 1/2, p85, CDC42, or ERK1/2 pathways.

10. The method of claim 1, wherein the nuclear reprogramming factor is encoded by a gene contained in a vector.

11. The method of claim 1, wherein the nuclear reprogramming factor is a SOX family gene, a KLF family gene, a MYC family gene, SALL4, OCT4, NANOG, LIN28, or a combination thereof.

12. The method of claim 1, wherein the nuclear reprogramming factor is one or more of OCT4, SOX2, KLF4, C-MYC.

13. The method of claim 1, wherein the nuclear reprogramming factor comprises c-Myc.

14. The method of claim 1, wherein the somatic cell is contacted with the reprogramming factor prior to, simultaneously with or following contacting with the microRNA.

15. The method of claim 1, wherein the somatic cell is a mammalian cell.

16. An induced pluripotent stem (iPS) cell produced using the method of claim 1.

17. An enriched population of induced pluripotent stern (iPS) cells produced by the method of claim 1.

18. A differentiated cell derived by inducing differentiation of the pluripotent stem cell produced by the method of claim 1.

19. A method of treating a subject comprising:

a) generating an induced pluripotent stem (iPS) cell from a somatic cell of the subject by the method of claim 1;

b) inducing differentiation of the iPS cell of step (a); and

c) introducing the cell of (b) into the subject, thereby treating the condition.

20. The use of microRNA for increasing efficiency of generating of iPS cells.

21. The use of claim 20, wherein the microRNA is selected from the group consisting of miR-17, miR-25, miR-93, miR-106a, miR-106b, miR-21, miR-29a, miR-302b cluster, miR let-7 family member or a combination thereof.

22. A combination of miR sequences selected from the group consisting of an least two or more of miR-17, miR-25, miR-93, miR-106a, miR-106b, miR-21, miR-29a, miR-302b cluster, miR let-7 family member, or a combination thereof.

23. A method of generating an induced pluripotent stem (iPS) cell comprising:

a) contacting a somatic cell with a nuclear reprogramming factor; and

b) contacting the cell of (a) with an inhibitor of microRNA, thereby generating an iPS cell.

24. The method of claim 23, wherein the microRNA is in the miR-17, miR-25, miR-106a, miR let-7 family member or miR-302b cluster.

25. The method of claim 23, wherein the microRNA is miR-93, miR-106b, miR-21, miR-29a, or a combination thereof.

26. The method of claim 23, wherein the microRNA regulates expression or activity of p21, Tgfbr2, p53, Ago2, or a combination thereof.

27. The method of claim 23, wherein the nuclear reprogramming factor is a SOX family gene, a KLF family gene, a MYC family gene, SALL4, OCT4, NANOG, LIN28, or a combination thereof.

28. The method of claim 23, wherein the somatic cell comprises a fibroblast.

29. An induced pluripotent stem (iPS) cell produced using the method of claim 23.